Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Cystic fibrosis transmembrane conductance regulator

Predicting Risk-Adjusted Incidence Rates of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in the Cystic Fibrosis Programs in the United States

  • Read more about Predicting Risk-Adjusted Incidence Rates of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in the Cystic Fibrosis Programs in the United States

Use of the CFTR modulator combination elexacaftor/tezacaftor/ivacaftor after lung transplant

  • Read more about Use of the CFTR modulator combination elexacaftor/tezacaftor/ivacaftor after lung transplant

Worldwide Estimates of Cystic Fibrosis Diagnosis and Treatment Access

  • Read more about Worldwide Estimates of Cystic Fibrosis Diagnosis and Treatment Access

How does the cystic fibrosis drug ivacaftor move in the body during pregnancy and breastfeeding?

  • Read more about How does the cystic fibrosis drug ivacaftor move in the body during pregnancy and breastfeeding?

CFTR plays an important role in the regulation of vascular resistance and high-fructose/salt-diet induced hypertension in mice

  • Read more about CFTR plays an important role in the regulation of vascular resistance and high-fructose/salt-diet induced hypertension in mice

Ivacaftor in Cystic Fibrosis With Residual Function: Lung Function Results From an N-of-1 Study

  • Read more about Ivacaftor in Cystic Fibrosis With Residual Function: Lung Function Results From an N-of-1 Study

Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.

  • Read more about Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.

Recommendations for the classification of diseases as CFTR-related disorders

  • Read more about Recommendations for the classification of diseases as CFTR-related disorders

Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis

  • Read more about Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)